Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ibrahim

Showing results (451-460 of 460) with videos related to

Pageof 46
Sort By:
You have reached the last page of results.This site can display upto 460 results.
JAMA Oncology|July 8, 2021
Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical TrialAndrew J Wagner, Paul L Severson, Anthony F Shields, et al.
Spine Deformity|December 9, 2016
Best Practices in Intraoperative Neuromonitoring in Spine Deformity Surgery: Development of an Intraoperative Checklist to Optimize ResponseMichael G Vitale, David L Skaggs, Gregory I Pace, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2009
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentDean R Artis, Jack J Lin, Chao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityJames Tsai, John T Lee, Weiru Wang, et al.
BMJ (Clinical Research Ed.)|May 31, 2023
Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation studyMarc Raynaud, Solaf Al-Awadhi, Ivana Juric, et al.
Nature|September 9, 2010
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, Peter Hirth, James Tsai, et al.
The New England Journal of Medicine|July 30, 2015
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell TumorWilliam D Tap, Zev A Wainberg, Stephen P Anthony, et al.
Molecular Psychiatry|July 20, 2016
Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yieldS Anazi, S Maddirevula, E Faqeih, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|November 1, 2015
Abdominal Wall MiscellaneousF Tai, J W Li, J Sun, et al.
La Tunisie Medicale|November 16, 2018
Poster abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018J Aarab, Ibtissem Abbess, Fathi Abdalla, et al.
Pageof 46

Showing results (451-460 of 460) with videos related to

Sort By:
Pageof 46
You have reached the last page of results.This site can display upto 460 results.
JAMA Oncology|July 8, 2021
Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical TrialAndrew J Wagner, Paul L Severson, Anthony F Shields, et al.
Spine Deformity|December 9, 2016
Best Practices in Intraoperative Neuromonitoring in Spine Deformity Surgery: Development of an Intraoperative Checklist to Optimize ResponseMichael G Vitale, David L Skaggs, Gregory I Pace, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 2009
Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentDean R Artis, Jack J Lin, Chao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityJames Tsai, John T Lee, Weiru Wang, et al.
BMJ (Clinical Research Ed.)|May 31, 2023
Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation studyMarc Raynaud, Solaf Al-Awadhi, Ivana Juric, et al.
Nature|September 9, 2010
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, Peter Hirth, James Tsai, et al.
The New England Journal of Medicine|July 30, 2015
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell TumorWilliam D Tap, Zev A Wainberg, Stephen P Anthony, et al.
Molecular Psychiatry|July 20, 2016
Clinical genomics expands the morbid genome of intellectual disability and offers a high diagnostic yieldS Anazi, S Maddirevula, E Faqeih, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|November 1, 2015
Abdominal Wall MiscellaneousF Tai, J W Li, J Sun, et al.
La Tunisie Medicale|November 16, 2018
Poster abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018J Aarab, Ibtissem Abbess, Fathi Abdalla, et al.
Pageof 46